Our results indicated that the cumulative median expression of FGFR1 (ILMN_1796229) mRNA was 1.802-fold (p < 0.05) higher in the poorly-differentiated dasatinib-resistant pancreatic cancer cells (SU8686, MiaPaCa2, and PANC-1) than in dasatinib-sensitive cells (PANC0403, PANC0504, and PANC1005) (Figure 1A, upper). This evidence concerns the gene FGFR1 and familial pancreatic carcinoma.